1
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid Tumours
Condition(s):Advanced Solid TumoursLast Updated:September 2, 2022Terminated
Advanced Solid Tumors: 6521 Clinical Trials, Page 1 of 653
Hide Studies Not Open or Pending
2
Study to Determine the Maximum Tolerated Dose (MTD) of PARPi 2X-121 Monotherapy and the MTD of Dovitinib in Combination With 2X-121 in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:February 2, 2023Recruiting
3
Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Solid Tumor
Condition(s):Advanced Solid TumorLast Updated:September 14, 2022Not yet recruiting
4
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Condition(s):Advanced Solid TumorLast Updated:April 29, 2019Recruiting
5
The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:February 24, 2023Recruiting
6
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:July 12, 2021Not yet recruiting
7
A Phaseâ… Study of HS-10381 in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:July 7, 2022Recruiting
8
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:March 14, 2023Recruiting
9
Phase 1/2 Study of HS-10370 in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:May 10, 2022Not yet recruiting
10
Study on the Tolerability and Pharmacokinetics of HX009 in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:February 16, 2023Active, not recruiting